Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

BL Cohen, DB Sachar - Bmj, 2017 - bmj.com
The treatment of inflammatory bowel disease (IBD)—ulcerative colitis (UC) and Crohn’s disease
(… agents, primarily antibodies against mediators of inflammation and cell attraction. Anti-…

[HTML][HTML] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease

F Hoentjen, AA Van Bodegraven - World journal of …, 2009 - ncbi.nlm.nih.gov
… Anti-tumor necrosis factor (TNF) therapy is currently used for the treatment of corticosteroid-…
-dependent, fistulizing Crohn’s disease, as well as refractory ulcerative colitis[2,3]. Anti-TNF …

Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease

TJ Ślebioda, Z Kmieć - Mediators of inflammation, 2014 - Wiley Online Library
Inflammatory bowel disease (IBD) is a group of inflammatory … forms are Crohn’s disease (CD)
and ulcerative colitis (UC). CD … and disruption of intestinal epithelial barrier. Members of the …

Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease

EJ Breese, CA Michie, SW Nicholls, SH Murch… - Gastroenterology, 1994 - Elsevier
… in inflammatory bowel disease (IBD). Many of the in vivo activities of tumor necrosis factor
a (… biopsy specimens of children with Crohn’s disease or ulcerative colitis (UC) and non-IBD …

Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease

C Stevens, G Walz, C Singaram, ML Lipman… - Digestive diseases and …, 1992 - Springer
… of IL-6 protein in inflammatory bowel disease specimens by … inflammatory bowel disease
specimens, suggesting that IL-6-mediated immune processes are ongoing in the inflammatory

Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease

L Peyrin-Biroulet, G Van Assche, D Gómez-Ulloa… - Clinical …, 2017 - Elsevier
… (CD) are chronic inflammatory conditions of the gut and comprise the main types of inflammatory
bowel disease (IBD). The main signs and symptoms of both UC and CD are observed …

Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease

NN Andersen, B Pasternak, S Basit, M Andersson… - Jama, 2014 - jamanetwork.com
… et al; Danish Crohn Colitis Database. Infliximab for inflammatory bowel disease in Denmark
1999… Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use …

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

SH Murch, CP Braegger, JA Walker-Smith… - Gut, 1993 - gut.bmj.com
… for tumour necrosis factor a (TNF a) in intestinal specimens from 24 patients with chronic
inflammatory bowel disease (15 with Crohn's disease, nine with ulcerative colitis) and 11 …

Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues

L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - journals.sagepub.com
… improvement or report intolerance to anti-tumour necrosis factor-α therapy. Optimizing …
the current use of tumour necrosis factor-α inhibitors in inflammatory bowel disease and the …

[HTML][HTML] Study of tumor necrosis factor receptor in the inflammatory bowel disease

RF Souza, MAF Caetano, HIR Magalhães… - World Journal of …, 2023 - ncbi.nlm.nih.gov
… Biological medicines for inflammatory bowel diseases. Biological medicines used for the
treatment of inflammatory bowel diseases (IBD) can be classified into anti- Tumor necrosis